Invention Grant
- Patent Title: Chemical compounds
-
Application No.: US16572917Application Date: 2019-09-17
-
Publication No.: US10793559B2Publication Date: 2020-10-06
- Inventor: Niall Andrew Anderson , Nicholas Paul Barton , Sebastien Andre Campos , Edward Paul Cannons , Anthony William James Cooper , Kenneth David Down , Kevin James Doyle , Julie Nicole Hamblin , Graham George Adam Inglis , Armelle Le Gall , Vipulkumar Kantibhai Patel , Simon Peace , Andrew Sharpe , Gemma Victoria White
- Applicant: GlaxoSmithKline Intellectual Property Development Limited
- Applicant Address: GB Brentford, Middlesex
- Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee Address: GB Brentford, Middlesex
- Agent Robert J. Smith
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@a7f98d4
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D213/76 ; A61P25/28 ; A61P11/06 ; A61P37/08 ; A61P25/24 ; A61P15/08
Abstract:
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
Public/Granted literature
- US20200071311A1 CHEMICAL COMPOUNDS Public/Granted day:2020-03-05
Information query
